A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

AIMS: The mechanistic basis of the symptoms and signs of myocardial ischaemia in patients without obstructive coronary artery disease (CAD) and evidence of coronary microvascular dysfunction (CMD) is unclear. The aim of this study was to mechanistically test short-term late sodium current inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Bairey Merz, C. Noel, Handberg, Eileen M., Shufelt, Chrisandra L., Mehta, Puja K., Minissian, Margo B., Wei, Janet, Thomson, Louise E.J., Berman, Daniel S., Shaw, Leslee J., Petersen, John W., Brown, Garrett H., Anderson, R. David, Shuster, Jonathan J., Cook-Wiens, Galen, Rogatko, André, Pepine, Carl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Aha Fasttrack
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872284/
https://www.ncbi.nlm.nih.gov/pubmed/26614823
http://dx.doi.org/10.1093/eurheartj/ehv647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872284/
https://www.ncbi.nlm.nih.gov/pubmed/26614823
http://dx.doi.org/10.1093/eurheartj/ehv647

Ejemplares similares